NDC properties for NDC 9 55513-482
NDC item 55513048201
| NDC 9 | 55513-482 |
|---|---|
| NDC 10 | 55513-482-01 |
| NDC Item | 55513048201 |
| packaging | 1 SYRINGE in 1 CARTON (55513-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 770230 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
NDC item 55513048202
| NDC 9 | 55513-482 |
|---|---|
| NDC 10 | 55513-482-02 |
| NDC Item | 55513048202 |
| packaging | 2 SYRINGE in 1 CARTON (55513-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 770230 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
NDC item 72511048201
| NDC 9 | 72511-482 |
|---|---|
| NDC 10 | 72511-482-01 |
| NDC Item | 72511048201 |
| packaging | 1 SYRINGE in 1 CARTON (72511-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 728860 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
NDC item 72511048202
| NDC 9 | 72511-482 |
|---|---|
| NDC 10 | 72511-482-02 |
| NDC Item | 72511048202 |
| packaging | 2 SYRINGE in 1 CARTON (72511-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 728860 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |